On Feb 25, 2026, BMA reported earnings of 201.13 USD per share (EPS) for Q4 25, beating the estimate of 186.77 USD, resulting in a 7.69% surprise. Revenue reached 1.88 trillion, compared to an expected 984.17 billion, with a 91.36% difference. The market reacted with a -8.29% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of 315.83 USD, with revenue projected to reach 4.28 trillion USD, implying an increase of 57.03% EPS, and increase of 127.40% in Revenue from the last quarter.